In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 827-830

  Faraut Gambarelli, Françoise ^a   Piarroux, Renaud ^a   Deniau, Michèle ^b   Giusiano, Bernard ^a   Marty, Pierre ^c   Michel, Gérard ^a   Faugère, Bernard ^a   Dumon, Henri ^a  

^a TIMONE HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c University of Côte d'Azur   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MEGLUMINE ANTIMONATE; PENTAMIDINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; LEISHMANIA; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; VISCERAL LEISHMANIASIS;

EID: 0030997216     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.827     Document Type: Article

References (20)

1. Alvar, J., R. Molina, M. San Andrés, M. Tesouro, J. Nieto, M. Vitutia, F. Gonzalez, M. D. San Andrés, J. Boggio, F. Rodriguez, A. Sainz, and C. Escacena. 1994. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann. Trop. Med. Parasitol. 88:371-378.
2. Berman, J. D., and L. S. Lee. 1984. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages. J. Parasitol. 70:220-225.
3. Berman, J. D., and D. J. Wyler. 1980. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J. Infect. Dis. 142:83-86.
4. Bryceson, A. D. M., J. D. Chulay, H. O. May, M. Mugambii, J. B. Were, R. Muigai, C. Chunge, G. Gachihi, J. Meme, G. Anabwani, and S. M. Bhatt. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans. R. Soc. Trop. Med. Hyg. 79:700-704.
5. Bryceson, A. D. M., W. Peters, and R. Killick-Kendrick. 1987. The leishmaniases in biology and medicine, p. 793-845. In W. Peters and R. Killick-Kendrick (ed.), Leishmaniases: clinical aspects and control, vol. 2. Academy Press, New York, N.Y.
6. Daniel, C., and F. S. Woods. 1971. Fitting equations to data. John Wiley and Sons, New York, N.Y.
7. Davidson, R. N., and S. Croft. 1993. Recent advances in the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 87:130-131.
8. Doenhoff, M. J., J. Modha, J. R. Lambertucci, and D. J. McLaren. 1991. The immune dependence of chemotherapy. Parasitol. Today 7:16-18.
9. Gramiccia, M., L. Gradoni, and S. Orsini. 1992. Decreased sensitivity to meglumine antimoniate (glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann. Trop. Med Parasitol. 86:613-620.
10. Grögl, M., A. M. Oduola, L. D. Cordero, and D. E. Kyle. 1989. Leishmania spp: development of pentostam-resistant clones in vitro by discontinuous drug exposure. Exp. Parasitol. 69:78-90.
11. Hendrickson, N., C. D. Sifri, D. M. Henderson, T. Allen, D. F. Wirth, and B. Ullman, 1993. Molecular characterization of the ldmdr 1 multidrug resistance gene from Leishmania donovani. Mol. Biochem. Parasitol. 60:53-64.
12. Neal, R. A., and S. L. Croft. 1984. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J. Antimicrob. Chemother. 14:463-475.
13. Ouellette, M., and B. Papadopoulou. 1993. Mechanisms of drug resistance in leishmania. Parasitol. Today 9:150-153.
14. Peter, B. S., D. Fish, R. Golden, D. A. Evans, A. D. M. Bryceson, and A. J. Pinching. 1990. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q. J. Med. 77:1101-1111.
15. Piarroux, R., M. Fontes, R. Perasso, F. Gambarelli, C. Joblet, H. Dumon. and M. Quilici. 1995. Phylogenetic relationships between old world Leishmania strains revealed by analysis of a repetitive DNA sequence. Mol. Biochem. Parasitol. 73:249-252.
16. Piarroux, R., J. M. Garnier, F. Gambarelli, H. Dumon, and D. Unal. 1996. Résistance de Leishmania infantum au glucantime®: circonstances de survenue et prise en charge thérapeutique. Arch. Pediatr. 3:352-356.
17. Ranque, J. 1980. Kala-Azar, p. 5-19. Encyclopédie médico-chirurgicale, vol. 10. Editions Techniques, Paris, France.
18. Rioux, J. A., G. Lanotte, E. Serres, F. Pratlong, P. Bastien, and J. Perieres. 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann. Parasitol. Hum. Comp. 65:111-125.
19. Wong, A. K. C., L. M. C. Chow, and D. F. Wirth. 1994. A homologous recombination strategy to analyze the vinblastin resistance property of the V-circle in Leishmania. Mol. Biochem. Parasitol. 64:75-86.
20. World Health Organization. 1982. Report of the informal meeting on chemotherapy of visceral leishmaniasis. TDR CHEMLEISH/VL. 3:2-14.